Study on the relationship between genetic polymorphisms of the β2-adrenoceptor and obesity in hypertensive patients

Chinese Pharmacological Bulletin

Volumn 22, Issue 2, 2006, Pages 154-159

  Mo, Wei ^a   Liu, Jie ^a   Zhou, Hong Hao ^a   Liu, Zhao Qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Haplotypes; Hypertension; Obesity; 2 adrenoceptor

Indexed keywords

AMINO ACID; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

EID: 33646263848     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Johnson D, Prudhomme D, Despres JP et al. Relation of abdominal obesity to hyperinsulinemia and high blood pressure in men [J]. Int J Obes, 1992, 16:881-90.
2. Croft JB, Strogatz DS, Keenan NL et al. The independent effects of obesity and body fat distribution on blood pressure in black adults: The Pitt County study[J]. Int J Obes, 1993, 17:391-7.
3. Bouchard C, Perusse L. Genetics of obesity[J]. Ann Rev Nutr. 1993, 13:337-54.
4. Williams RR, Hunt SC, Hasstedt SJ et al. Multigenic human hypertension: Evidence for subtypes and hope for haplotypes[J]. J Hypertens, 1990, 8 (Suppl. 7):S39-S46.
5. Krieger DR, Landsberg L. Obesity and Hypertension[M]. In: Laragh JH, Brenner BM eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1990:1741-57.
6. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk[J]. Cardiovasc Pharmacol, 1992, 20 (Suppl 8):S40-S8.
7. Rocchini AP. Cardiovascular regulation in obesity-induced hypertension[J]. Hypertension, 1992, 19:156-60.
8. Julius S. The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension[J]. Clin Exp Hypertens, 1996, 18:305-21.
9. Lipworth BJ. Clinical pharmacology of [beta] 3-adrenoceptors [J]. British J Clin Pharmacol, 1996, 42(3):291-300.
10. 2-adrenergic receptor in normal and asthmatic subjects[J]. Am J Respir Cell Mol Biol. 1993, 8:334-9.
11. 2-adrenergic receptor polymorphisms: relevance to receptor function and asthmatic phenotypes[M]. In Liggett SB, Meyers DA. The Genetics of Asthma. Marcel Dekker, New York, 1996:455-78.
12. Ellsworth DL, Coady SA, Chen W et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through yound adulthood in a biracial cohort: the Bogalusa Heart Study[J]. Intern J Obesity, 2002, 26:928-37.
13. Meirhaeghe A, Luan JA, Selberg-Franks P et al. The effect of the Gly16Arg Polymorphism of the beta2-Adrenergic receptor gene on plasma free fatty acid levels is modulated the physical activity[J]. J Clin Endocrinol Metabol, 2001, 86(12):5881-7.
14. 2 adrenoreceptor is associated with type 2 diabetes in Taiwanese people[J]. Clinical Endocrinol, 2002, 57:685-90.
15. McGraw DW, Forbes SL, Kramer LA et al. Polymorphism of the 5 prime leader cistron of the human beta-2 adrenergic receptor regulates receptor expression[J]. J Clin Investigation, 1998, 102:1927-32.
16. 2- Adrenergic Receptor Variant Is Associated with Obesity Due to Subcutaneous Fat Accumulation in Japanese Men[J]. Biochem Biophys Res Commun, 1999, 258:138-40.
17. 2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med, 2000, 247:651-6.
18. 2-adrenoceptor gene polymorphism on obesity in males and in females[J]. J Intern Med, 1999, 245:253-9.
19. 2-adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding[J]. Int J Obes Relat Metab Disord, 2001, 25:1604-8.
20. 2-adrenoceptor gene on obesity in a French population[J]. Int J Obes Relat Metab Disord, 2000, 24:382-7.
21. Lonnqvist F, Thorne A, Large V et al. Sex differences in visceral fat lipolysis and metabolic complications of obesity[J]. Arterioscler Thromb Vasc Biol, 1997, 17:1472-80.
22. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome[J]. Endocr Rev, 2000, 21:697-738.
23. Raison JM, Achimastos AM, Safar ME. Sex-dependence of body fat distribution in patients with obesity and hypertension[J]. Clin Exp Hypertens, 1992, 14:505-25.
24. Krief S, Lonnqvist F, Raimbault S et al. Tissue distribution of beta3-adrenergic receptor mRNA in man[J]. J Clin Invest, 1993, 91:344-9.